Juha T.
- Country
- Finland
- Department
- TAYS tutkimuspalvelut
Research Overview
- Safety and Tolerability Assessment of TEV-53408 in Adult Patients with Celiac Disease: A Phase 1b Clinical Trial
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANB033 in Patients with Celiac Disease
- Efficacy and Tolerability of ZED1227 in Patients with Celiac Disease Experiencing Symptoms Despite a Gluten-Free Diet: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial
Data & Insights
Has run more than one trial at 19 of 107 partner sites.
Specializations
Gastrointestinal Disorders
The investigator specializes in celiac disease research, with particular emphasis on developing therapeutic interventions for patients experiencing persistent symptoms despite dietary management.
- Non-responsive celiac disease (NRCD)
- Intestinal mucosal healing
- Gluten-induced pathology
Their work explores innovative therapeutic approaches for managing celiac disease complications and improving patient outcomes.
Therapeutic Innovation
The investigator focuses on evaluating novel therapeutic compounds targeting various aspects of celiac disease pathophysiology, including mucosal damage and symptom management.
- Targeted immunotherapy
- Symptom reduction strategies
- Mucosal recovery assessment
Their research encompasses both subcutaneous and oral therapeutic interventions for celiac disease treatment.
Clinical Assessment
The investigator specializes in evaluating treatment efficacy through comprehensive clinical assessments and specialized diagnostic measures.
- Duodenal histology evaluation
- Symptom diary assessment
- Gluten challenge responses
Their expertise includes analyzing both histological and clinical parameters in celiac disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.